APA (7th ed.) Citation

F, R., B, C., M, M., D, M., R, E., D, B., . . . E, M. (2023). Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries. Vaccine, 41(47), 7007. https://doi.org/10.1016/j.vaccine.2023.10.011

Chicago Style (17th ed.) Citation

F, Riefolo, et al. "Effectiveness of Homologous/heterologous Booster COVID-19 Vaccination Schedules Against Severe Illness in General Population and Clinical Subgroups in Three European Countries." Vaccine 41, no. 47 (2023): 7007. https://doi.org/10.1016/j.vaccine.2023.10.011.

MLA (9th ed.) Citation

F, Riefolo, et al. "Effectiveness of Homologous/heterologous Booster COVID-19 Vaccination Schedules Against Severe Illness in General Population and Clinical Subgroups in Three European Countries." Vaccine, vol. 41, no. 47, 2023, p. 7007, https://doi.org/10.1016/j.vaccine.2023.10.011.